| Pharmacokinetics of a Standard Paracetamol Tablet and Oral Solution After Oral Administration in Chinese Healthy Volunteers (NCT02095704) | Central South University | 2013-05-01 |
| Clinical Investigation of Erlotinib as an HCV Entry Inhibitor (NCT01835938) | University Hospital, Strasbourg, France | 2013-05-01 |
| A Drug Interaction Study of Mosapride and Rebamipide (NCT02106130) | IlDong Pharmaceutical Co Ltd | 2013-05-01 |
| Acute Dose Response of Korean White Ginseng in Metabolic Syndrome or Type 2 Diabetes (NCT01699074) | Unity Health Toronto | 2013-05-01 |
| Comparing Triamcinolone Acetonide Mucoadhesive Films With Licorice Mucoadhesive Films (NCT02075749) | Isfahan University of Medical Sciences | 2013-05-01 |
| DHA Supplementation for Lactating Mothers (NCT01732874) | Children's Hospital Medical Center, Cincinnati | 2013-05-01 |
| AME (Absorption, Metabolism, and Excretion) of Radiolabeled SSP-004184 (NCT01824446) | Shire | 2013-05-01 |
| Relative Bioavailability of Pyronaridine-artesunate in Tablet and Granule Formulations in Healthy Volunteers (NCT01868438) | Medicines for Malaria Venture | 2013-05-01 |
| Phase I Study of the Volitinib (HMPL-504) in Patients With Advanced Solid Tumors (NCT01985555) | Hutchison Medipharma Limited | 2013-05-01 |
| A Study to Assess the Safety, Tolerability and Pharmacokinetics of AVI-7288 in Healthy Adult Volunteers (NCT01566877) | Sarepta Therapeutics, Inc. | 2013-05-01 |
| Brentuximab Vedotin + Re-induction Chemotherapy for AML (NCT01830777) | Massachusetts General Hospital | 2013-05-01 |
| Safety, Tolerability and Pharmacokinetics in AD Subjects and Healthy Subjects of Cutaneous Application of LEO 39652 Cream (NCT01850849) | LEO Pharma | 2013-05-01 |
| Phase I Study of Mitoxantrone Hydrochloride Liposome Injection (NCT02131688) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2013-05-01 |
| Evaluation of a Multi-phosphopeptide Vaccine Plus PolyICLC in Participants With High Risk and Advanced Malignancies (NCT01846143) | Craig L Slingluff, Jr | 2013-05-01 |
| An Assessment of the Safety and Pharmacokinetics of Ascending Doses of SANGUINATE™ in Healthy Volunteers. (NCT01847222) | Prolong Pharmaceuticals | 2013-05-01 |
| Effectiveness of Adherence Therapy for Schizophrenia (NCT01780116) | The Hong Kong Polytechnic University | 2013-05-01 |
| GP2013 in Japanese Patients With CD20 Positive Low Tumor Burden Indolent B-cell Non-Hodgkin's Lymphoma (NCT01933516) | Sandoz | 2013-05-01 |
| Minocycline Bioequivalence Study (NCT01938508) | GlaxoSmithKline | 2013-05-01 |
| Impact of Sonifilan on the Quality of Life in Patients With Cervical Cancer During Radiation or Chemoradiation Therapy (NCT01926821) | Asan Medical Center | 2013-05-01 |
| Safety and Pharmacokinetics of NRX-1074 in Normal Volunteers (NCT01856556) | Naurex, Inc, an affiliate of Allergan plc | 2013-05-01 |
| The Sun Protective Effect of Melatonin (NCT01873430) | Herlev Hospital | 2013-05-01 |
| Repeat Dose Tolerance Study of Regadenoson in Healthy Subjects (NCT01918995) | Astellas Pharma Global Development, Inc. | 2013-05-01 |
| Phase 1 Dose Finding Study of Belinostat for Treatment of Patients With Peripheral T-cell Lymphoma (PTCL) (NCT01839097) | Acrotech Biopharma Inc. | 2013-05-01 |
| CPI-613 in Treating Patients With Advanced or Metastatic Bile Duct Cancer That Cannot Be Removed By Surgery (NCT01766219) | Wake Forest University Health Sciences | 2013-05-01 |
| Topical Anti-angiogenic Therapy for Telangiectasia in HHT: Proof of Concept (NCT01752049) | Unity Health Toronto | 2013-05-01 |
| Efficacy and Tolerability of NM-BL in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis (NCT01710644) | Nordmark Arzneimittel GmbH & Co. KG | 2013-05-01 |
| Pharmacologic Response and Safety of Inhaled Insulin in Type 1 Diabetes (NCT02713841) | Dance Biopharm Inc. | 2013-05-01 |
| Effects of Fish Oil on the Colon Mucosa (NCT01860352) | University of Michigan | 2013-05-01 |
| Study to Assess the Effect of BMS-791325 on the Pharmacokinetics of Midazolam in Healthy Subjects (NCT00996879) | Bristol-Myers Squibb | 2013-05-01 |
| 3-part Study to Evaluate Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of Multiple Doses of CC-220 and Relative Bioavailability of a Formulated CC-220 Capsule (NCT02034773) | Celgene Corporation | 2013-05-01 |
| Trial of Bilateral tDCS for Depression (NCT01849367) | The University of New South Wales | 2013-05-01 |
| BioRBC Survival in Adults With Prior Antibody Response to BioRBCs (NCT02077751) | John A Widness | 2013-05-01 |
| A Study of DKN-01 and Lenalidomide/Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma (NCT01711671) | Leap Therapeutics, Inc. | 2013-05-01 |
| Evaluation of Tolerance, Suckling and Food Intake After Repeated Nasals Administrations of Oxytocin in PWS Infants (NCT02205034) | University Hospital, Toulouse | 2013-05-01 |
| Phase 1 Study to Assess the Safety of Inactivated Split Influenza Vaccine and Control Vaccine in Korean Volunteer (NCT02330003) | Il-Yang Pharm. Co., Ltd. | 2013-05-01 |
| Effects of Pregnancy and Childbirth on Pelvic Floor Morphology and Sexual Function in Egyptian Women (NCT02338219) | Al-Azhar University | 2013-05-01 |
| Rituximab Plus Chemotherapy in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (NCT04361409) | China Medical University Hospital | 2013-05-01 |
| Pharmacokinetics and Side Effects of the mGlu5 Antagonist Fenobam in Adult Healthy Volunteers (NCT01806415) | Washington University School of Medicine | 2013-05-01 |
| Bioavailability in Patient With Psoriasis: Metoject Prefilled Pen (NCT02097173) | medac GmbH | 2013-05-01 |
| Study of the Electrocardiographic Effects of Ranolazine, Dofetilide, Verapamil, and Quinidine in Healthy Subjects (NCT01873950) | Food and Drug Administration (FDA) | 2013-05-01 |
| A Phase 1 Study to Assess the Safety,Tolerability, and Pharmacokinetics of GS-6615 in Healthy Subjects (NCT01847391) | Gilead Sciences | 2013-05-01 |
| Absorption, Metabolism, and Excretion of a Single Dose of Ferriprox® in Patients With Sickle Cell Disease (NCT01835496) | ApoPharma | 2013-05-01 |
| Comparison of Salmeterol and Fluticasone Propionate Absorption From Salmeterol/Fluticasone Easyhaler With Seretide Diskus (NCT01856621) | Orion Corporation, Orion Pharma | 2013-05-01 |
| Study of IPI-145 in Combination With Rituximab or Bendamustine/Rituximab in Hematologic Malignancies (NCT01871675) | SCRI Development Innovations, LLC | 2013-05-01 |
| Phase I Trial of Intraperitoneal Bevacizumab in Refractory Malignant Ascites (NCT01852409) | Peking University | 2013-05-01 |
| Relative Bioavailability of Oral Suspension of Rivaroxaban Compared to Standard Tablet (NCT01853800) | Bayer | 2013-05-01 |
| Bioequivalence of Orfadin 20 mg Compared to Orfadin 10 mg Capsules. (NCT01857362) | Swedish Orphan Biovitrum | 2013-05-01 |
| A Phase I/Ib Study of AZD9150 (ISIS-STAT3Rx) in Patients With Advanced/Metastatic Hepatocellular Carcinoma (NCT01839604) | AstraZeneca | 2013-05-01 |
| Photodynamic Therapy (PDT) for Oral Disinfection (NCT02152475) | University of Sao Paulo | 2013-05-01 |
| Clinical Trial to Compare The Pharmacokinetics of A Pregabalin Controlled Release Tablet 300mg and Immediate Release Formulation (NCT02103647) | IlDong Pharmaceutical Co Ltd | 2013-05-01 |
| Long-Term Efficacy and Safety of CT-P10 in Patients With RA (NCT01873443) | Celltrion | 2013-05-01 |
| A Phase 1/2A Study of LAM561 in Adult Patients With Advanced Solid Tumours (NCT01792310) | Laminar Pharmaceuticals | 2013-05-01 |
| Study Comparing the Pharmacokinetics, Pharmacodynamics, and Safety of K-312 in Healthy Adult Volunteers (NCT01952548) | Kowa Research Institute, Inc. | 2013-05-01 |
| Natalizumab in Inclusion Body Myositis (IBM) (NCT02483845) | Phoenix Neurological Associates, LTD | 2013-05-01 |
| A Pivotal Bioequivalence Study of DOXIL/CAELYX (Doxorubicin HCL) in Patients With Advanced or Refractory Solid Malignancies Including Patients With Ovarian Cancer (NCT01815294) | Janssen Research & Development, LLC | 2013-05-01 |
| Safety, Tolerability, PK & PD Study of JTZ-951 in Anemic Subjects With End-stage Renal Disease (NCT01971164) | Akros Pharma Inc. | 2013-05-01 |
| Pilot Study: Effects of Psilocybin on Behavior, Psychology and Brain Function in Long-term Meditators (NCT01988311) | Johns Hopkins University | 2013-05-01 |
| A Japanese Phase 1 Trial of c-Met Inhibitor MSC2156119J in Subjects With Solid Tumors (NCT01832506) | Merck KGaA, Darmstadt, Germany | 2013-04-30 |
| Booster Dose (50 µg) of Recombinant Ricin Toxin Vaccine (RVEc™) in Previously Vaccinated Healthy Adults (NCT01846104) | U.S. Army Medical Research and Development Command | 2013-04-30 |
| Lithium Carbonate and Tretinoin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia (NCT01820624) | Paolo Caimi, MD | 2013-04-30 |
| Crizotinib and Combination Chemotherapy in Treating Younger Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell Lymphoma (NCT01606878) | Children's Oncology Group | 2013-04-29 |
| The Bioequivalence Study of Lamotrigine Dispersible/Chewable Tablets 5mg×5 Compared With Lamotrigine Compressed Tablet 25mg in Chinese Healthy Male Subjects (NCT01879423) | GlaxoSmithKline | 2013-04-28 |
| Lenalidomide and Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (NCT01886859) | National Cancer Institute (NCI) | 2013-04-26 |
| A Phase I Trial of the Combination of AZD2014 and Weekly Paclitaxel. (NCT02193633) | Royal Marsden NHS Foundation Trust | 2013-04-26 |
| Study of Pembrolizumab (MK-3475) Monotherapy in Advanced Solid Tumors and Pembrolizumab Combination Therapy in Advanced Non-small Cell Lung Cancer/ Extensive-disease Small Cell Lung Cancer (MK-3475-011/KEYNOTE-011) (NCT01840579) | Merck Sharp & Dohme LLC | 2013-04-26 |
| Phase I/II Carfilzomib Plus Lenalidomide and Rituximab in the Treatment of Relapsed/Refractory Mantle Cell Lymphoma (NCT01729104) | M.D. Anderson Cancer Center | 2013-04-25 |
| Bioavailability and Food Effect of the Original Gelatin Formulation and Two New Formulations of Afuresertib in Normal Healthy Volunteers (NCT01827644) | GlaxoSmithKline | 2013-04-24 |
| Cardiac Allograft Remodeling and Effects of Sirolimus (NCT01889992) | University of Nebraska | 2013-04-24 |
| A Phase I Trial of AZD3965 in Patients With Advanced Cancer (NCT01791595) | Cancer Research UK | 2013-04-23 |
| Study of Romosozumab (AMG 785) Administered to Healthy Participants and Patients With Stage 4 Renal Impairment or Stage 5 Renal Impairment Requiring Hemodialysis (NCT01833754) | Amgen | 2013-04-22 |
| Safety, Tolerability and Pharmacokinetics of BI 409306 Tablets in Healthy Asian Male Volunteers (NCT01841112) | Boehringer Ingelheim | 2013-04-22 |
| APBI Proton Feasibility and Phase II Study (NCT01839838) | Abramson Cancer Center at Penn Medicine | 2013-04-22 |
| Ultrasound-Guided Photodynamic Therapy With Photofrin & Gemcitabine for Patients With Locally Advanced Pancreatic Cancer (NCT01770132) | John DeWitt | 2013-04-19 |
| A Japanese Phase 1 Trial of TH-302 in Subjects With Solid Tumors and Pancreatic Cancer (NCT01833546) | Merck KGaA, Darmstadt, Germany | 2013-04-18 |
| Transplantation of Autologous Oral Mucosal Epithelial Sheets for Limbal Stem-cell Deficiency (NCT02415218) | Siriraj Hospital | 2013-04-17 |
| Evaluation of the Safety and Pharmacokinetics of MSI-195 to a Commercial S-Adenosylmethionine (NCT04623034) | MSI Methylation Sciences, Inc. | 2013-04-17 |
| Nitisinone for Type 1B Oculocutaneous Albinism (NCT01838655) | National Eye Institute (NEI) | 2013-04-16 |
| A Phase I/IIa Study of UV1 Vaccine in Patients With Prostate Cancer (NCT01784913) | Ultimovacs ASA | 2013-04-15 |
| A Trial to Evaluate the Abuse Potential of 3 Doses of GRT6005 in Adult Non-dependent Recreational Opioid Users (NCT03757559) | Tris Pharma, Inc. | 2013-04-15 |
| Azacitidine in Patients Undergoing Matched Unrelated Stem Cell Transplantation (NCT01747499) | Washington University School of Medicine | 2013-04-15 |
| Study of MLN4924 Plus Azacitidine in Treatment-naive Participants With Acute Myelogenous Leukemia (AML) Who Are 60 Years or Older (NCT01814826) | Millennium Pharmaceuticals, Inc. | 2013-04-10 |
| ADH-1, Gemcitabine Hydrochloride & Cisplatin in Treating Metastatic Pancreatic or Biliary Tract Cancer (NCT01825603) | University of Nebraska | 2013-04-09 |
| Ipilimumab, Cetuximab, and Intensity-Modulated Radiation Therapy in Treating Patients With Previously Untreated Stage III-IVB Head and Neck Cancer (NCT01935921) | National Cancer Institute (NCI) | 2013-04-09 |
| Active Preoperative Anemia Management in Patients Undergoing Cardiac Surgery (NCT02189889) | University of Texas Southwestern Medical Center | 2013-04-09 |
| Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma (NCT01798004) | Children's Oncology Group | 2013-04-09 |
| Viral Therapy In Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Cancer or Metastatic Breast Cancer (NCT01846091) | Mayo Clinic | 2013-04-09 |
| A Phase I/IIa Study of UV1 Vaccination in Patients With Non Small Cell Lung Cancer. (NCT01789099) | Ultimovacs ASA | 2013-04-08 |
| Pomalidomide and Dexamethasone in Treating Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma or Newly Diagnosed or Relapsed or Refractory Intraocular Lymphoma (NCT01722305) | Mayo Clinic | 2013-04-08 |
| Mebendazole in Newly Diagnosed High-Grade Glioma Patients Receiving Temozolomide (NCT01729260) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2013-04-04 |
| Assess Safety & Efficacy of Selumetinib When Given in Combination With Standard First Line Treatment for Advanced Non-small Cell Lung Cancer (NCT01809210) | AstraZeneca | 2013-04-04 |
| A Fixed Dose Combination Amlodipine + Enalapril Bioavailability Study (NCT01822639) | GlaxoSmithKline | 2013-04-03 |
| Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme (NCT01800695) | AbbVie | 2013-04-02 |
| Autologous Adipose Stem Cells and Platelet Rich Plasma Therapy for Patients With Knee Osteoarthritis (NCT02142842) | University of Science Ho Chi Minh City | 2013-04-01 |
| Sipuleucel-T and Ipilimumab for Advanced Prostate Cancer (NCT01832870) | Prostate Oncology Specialists, Inc. | 2013-04-01 |
| Safety and Tolerability Study With Single Ascending Doses of ODM-102 (NCT01839019) | Orion Corporation, Orion Pharma | 2013-04-01 |
| Safety and Efficacy of Ingenol Mebutate Once Daily for 2 or 3 Consecutive Days in Subjects With Actinic Keratosis (NCT01820260) | LEO Pharma | 2013-04-01 |
| Safety of Single Rising Doses and Relative Bioavailability of BI 691751 (NCT01843972) | Boehringer Ingelheim | 2013-04-01 |
| Assess Safety, Bio-distribution, Radiation Dosimetry and Optimize the Imaging Protocol of GEH120714 (18F) Injection in Healthy Volunteers and Participants With Relapsing and Remitting Multiple Sclerosis (rrMS). (NCT01738347) | GE Healthcare | 2013-04-01 |
| A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposomal Injection (NCT01829971) | Mirna Therapeutics, Inc. | 2013-04-01 |
| Enhancing Influenza Vaccination in Seniors With TLR (Toll Like Receptor) Agonists (NCT01737580) | University of British Columbia | 2013-04-01 |